Costabel, U., Bendstrup, E., Cottin, V., Dewint, P., Egan, J. J. J., Ferguson, J., . . . Vancheri, C. (2014). Pirfenidone in idiopathic pulmonary fibrosis: Expert panel discussion on the management of drug-related adverse events. Advances in therapy, 31(4), . https://doi.org/10.1007/s12325-014-0112-1
Chicago Style (17th ed.) CitationCostabel, Ulrich, et al. "Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-related Adverse Events." Advances in Therapy 31, no. 4 (2014). https://doi.org/10.1007/s12325-014-0112-1.
MLA (9th ed.) CitationCostabel, Ulrich, et al. "Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-related Adverse Events." Advances in Therapy, vol. 31, no. 4, 2014, https://doi.org/10.1007/s12325-014-0112-1.